Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00443430 · ClinicalTrials.gov registry record · Phase 4

Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis

A Phase 4 study of Juvenile Idiopathic Arthritis and Juvenile Rheumatoid Arthritis, sponsored by Seattle Children's Hospital.

Completed
Registry status
Phase 4
Development phase
85
Enrollment target
15
Study locations

NCT00443430 is a Phase 4 study of Juvenile Idiopathic Arthritis and Juvenile Rheumatoid Arthritis that has completed, run by Seattle Children's Hospital. The registered enrollment target is 85 participants, below the 292-participant average among 8 other Juvenile Idiopathic Arthritis trials with a reported enrollment target (71% lower). The trial reports 15 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00443430, a Phase 4 study of Juvenile Idiopathic Arthritis and Juvenile Rheumatoid Arthritis, has completed, sponsored by Seattle Children's Hospital.

COMPLETED
Registry status
Phase 4
Development phase
85 participants
Enrollment target
15
Study locations

Study Summary

The purpose of this study is to compare two aggressive drug regimens for children with poly-juvenile idiopathic arthritis (JIA) and extended oligo JIA.

Conditions Studied

Juvenile Idiopathic Arthritis Juvenile Rheumatoid Arthritis Juvenile Chronic Polyarthritis

Interventions

  • DRUG methotrexate
  • DRUG methotrexate - etanercept - prednisolone arm

Study Locations (15)

California

  • Stanford University Medical Center - Palo Alto
  • Rady Children's Hospital - San Diego
  • University of California San Francisco Medical Center - San Francisco

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati
  • Cleveland Clinic Foundation - Cleveland
  • Children's Hospital of Columbus - Columbus

New York

  • Schneider Children's Hospital - New Hyde Park
  • Children's Hospital at Montefiore - The Bronx

Massachusetts

  • Children's Hospital of Boston - Boston

New Jersey

  • Hackensack University Medical Center - Hackensack

North Carolina

  • Duke University - Durham

Oklahoma

  • Oklahoma University Health Science Center - Oklahoma City

Texas

  • Texas Scottish Rite Hospital - Dallas

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2007-05
Est. Completion 2010-10
Phase Phase 4

Sponsor

Seattle Children's Hospital

168 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00443430

The ClinicalTrials.gov registry entry for NCT00443430 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 292-participant average among 8 other Juvenile Idiopathic Arthritis trials with a reported enrollment target (71% lower). The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Juvenile Idiopathic Arthritis appearing as the primary indexed condition, and to 2 interventions - of which methotrexate is the first listed.

NCT00443430 reports 15 study locations spanning 10 distinct geographic areas - top geographies include California, Ohio, New York.

Frequently Asked Questions

What is clinical trial NCT00443430 about?

NCT00443430 is a clinical study titled "Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis". The purpose of this study is to compare two aggressive drug regimens for children with poly-juvenile idiopathic arthritis (JIA) and extended oligo JIA.

What is the current status of trial NCT00443430?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 85 participants. The study started on 2007-05. Estimated completion is 2010-10.

What conditions does trial NCT00443430 study?

This clinical trial studies the following conditions: Juvenile Idiopathic Arthritis, Juvenile Rheumatoid Arthritis, Juvenile Chronic Polyarthritis.

What interventions are being tested in trial NCT00443430?

The interventions under investigation include: methotrexate (DRUG), methotrexate - etanercept - prednisolone arm (DRUG).

Who is sponsoring clinical trial NCT00443430?

This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00443430 being conducted?

This trial has 15 study locations across California, Massachusetts, New Jersey, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Juvenile Idiopathic Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Juvenile Idiopathic Arthritis

All registered trials for this condition

Juvenile Rheumatoid Arthritis

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.